Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Double-blind, Placebo Controlled, Parallel Clinical Trial for the Evauation of the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia

NCT07016269 is registered in ClinicalTrials.gov with Myungmoon Pharma. Co. Ltd. as lead sponsor.

NCT NCT07016269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07016269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Double-blind, Placebo Controlled, Parallel Clinical Trial for the Evauation of the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
Lead sponsor
Myungmoon Pharma. Co. Ltd.
Phase
Phase 4
Overall status
Recruiting
Start date
August 29, 2025
Completion date
June 13, 2028
Enrollment
358 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

biliary dyspepsia